Sabrina Johnson
CEO,
Daré Bioscience
United States
Sabrina Martucci Johnson is a life sciences executive committed to advancing innovation in women’s health. She is the Founder and CEO of Daré Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven by a mission to transform the health and well-being of women in the areas of contraception, sexual health, infectious disease, menopause and pelvic pain. Sabrina has a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change. Prior to founding Daré, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research (currently Calibr-Skaggs Institute for Innovative Medicines, part of Scripps Research), CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB), held marketing and sales positions with Advanced Tissue Sciences, and began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on the recombinant factor VIII program.
Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.
Sessions
-
10-Feb-2025Daré Bioscience
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}